Related Experiment Videos
ECMO in newborn infants: the Melbourne experience.
1Royal Children's Hospital, Parkville, Victoria, Australia.
Journal of Paediatrics and Child Health
|December 1, 1992
Summary
Extracorporeal membrane oxygenation (ECMO) offers a life-saving treatment for newborns with severe respiratory or cardiac failure. This therapy demonstrates a high survival rate, with most survivors achieving normal long-term function.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Pediatric Pulmonology
Background:
- Neonatal respiratory and cardiac failure pose significant life-threatening risks.
- Extracorporeal membrane oxygenation (ECMO) is a critical intervention for critically ill neonates.
Purpose of the Study:
- To evaluate the efficacy and outcomes of ECMO in newborn infants with cardiorespiratory failure.
- To assess the long-term functional status of infants treated with ECMO.
Main Methods:
- Retrospective analysis of newborn infants treated with ECMO from May 1989.
- Inclusion criteria: reversible condition, likelihood of normal survival, and 80% mortality risk without ECMO.
Main Results:
- 73% (16 of 22) of infants survived at least 6 months post-ECMO.
- 87.5% of non-congenital diaphragmatic hernia infants were functionally normal survivors.
- 2 of 6 infants with congenital diaphragmatic hernia achieved normal 6-month neurological and respiratory function.
Conclusions:
- ECMO is an effective therapy for neonates with otherwise fatal cardiorespiratory failure.
- The treatment yields favorable outcomes, including normal long-term function in a majority of survivors.
- Results align with international findings, supporting ECMO's role in neonatal critical care.